Please enable JavaScript to continue using this application.

Compare $CRBU vs $CRVO | Chartloom

Compare

$CRBU vs $CRVO

Caribou Biosciences Inc · CervoMed Inc

CRBU

Caribou Biosciences Inc

CRVO

CervoMed Inc

Compare $CRBU vs $CRVO

Comparing Caribou Biosciences Inc and CervoMed Inc

CRBUCaribou Biosciences Inc

CRVOCervoMed Inc

CRBUCaribou Biosciences Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

10.0%

YTD performance

-71.1%

52W performance

-82.8%

FCF yield

-210.7%

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBU

CRVO

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

CRVO

CervoMed Inc

Market Cap

CRBU$46M

CRVO$44M

Enterprise Value

CRBU$19M

CRVO$21M

Price

CRBU$0.46

CRVO$3.22

P/E Ratio

CRBUN/A

CRVON/A

P/S Ratio

CRBU4.55x

CRVO131.50x

EV/Sales

CRBU1.94x

CRVO63.70x

EV/EBITDA

CRBU0.00x

CRVO0.00x

P/B Ratio

CRBU1.33x

CRVO1.99x

P/FCF Ratio

CRBUN/A

CRVON/A

EV/FCF

CRBU-0.20x

CRVO-0.75x

PEG Ratio

CRBUN/A

CRVON/A

Forward P/E (NTM)

CRBUN/A

CRVON/A

Forward P/S (NTM)

CRBUN/A

CRVON/A

Revenue (TTM)

CRBU$10M

CRVO$331K

Revenue Growth (YoY)

CRBU10.0%

CRVO-95.7%

Forward Rev Growth

CRBU15.8%

CRVO2153.6%

Gross Margin (TTM)

CRBU0.0%

CRVO0.0%

Operating Margin (TTM)

CRBU0.0%

CRVO0.0%

EBITDA Margin (TTM)

CRBU-1065.1%

CRVO-9406.8%

Net Margin (TTM)

CRBU-1030.4%

CRVO-9160.8%

FCF Margin (TTM)

CRBU-958.5%

CRVO-8444.8%

Net Income (TTM)

CRBU$-103M

CRVO$-30M

FCF (TTM)

CRBU$-96M

CRVO$-28M

EPS (TTM)

CRBU-$1.02

CRVO-$2.96

ROE (TTM)

CRBU-8911.0%

CRVO-15602.0%

ROA (TTM)

CRBU-6247.0%

CRVO-12834.0%

ROIC (TTM)

CRBU-8911.0%

CRVO-15602.0%

Cash

CRBU$26M

CRVO$22M

Debt

CRBU$0

CRVO$0

Net Cash/Debt

CRBU$26M

CRVO$22M

Current Ratio (TTM)

CRBU6.49x

CRVO8.57x

Quick Ratio (TTM)

CRBU6.36x

CRVO8.36x

Debt/Equity (TTM)

CRBU0.00x

CRVO0.00x

Debt/Assets (TTM)

CRBU0.0%

CRVO0.0%

Interest Coverage (TTM)

CRBUN/A

CRVON/A

Net Debt/EBITDA (TTM)

CRBU0.00x

CRVO0.00x

Beta

CRBU2.46

CRVO-0.69

52W Performance

CRBU-82.8%

CRVO-63.8%

YTD Performance

CRBU-71.1%

CRVO-58.7%

% from 52W High

CRBU-87.0%

CRVO-67.8%

% from 52W Low

CRBU4.0%

CRVO51.2%

Asset Turnover (TTM)

CRBU0.06x

CRVO0.07x

FCF Yield (TTM)

CRBU-210.7%

CRVO-64.2%

Earnings Yield (TTM)

CRBU-226.5%

CRVO-69.7%

Dividend Yield (TTM)

CRBUN/A

CRVON/A

Rule of 40

CRBU-948.5

CRVO-8,540.5

EV/GP/RG

CRBUN/A

CRVON/A

Ticker research

View CRBU research View CRVO research

Metric	CRBU Caribou Biosciences Inc	CRVO CervoMed Inc
Market & Valuation
Market Cap	$46M	$44M
Enterprise Value	$19M	$21M
Price	$0.46	$3.22
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	131.50x
EV/Sales	1.94x	63.70x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	1.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$331K
Revenue Growth (YoY)	10.0%	-95.7%
Forward Rev Growth	15.8%	2153.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1065.1%	-9406.8%
Net Margin (TTM)	-1030.4%	-9160.8%
FCF Margin (TTM)	-958.5%	-8444.8%
Net Income (TTM)	$-103M	$-30M
FCF (TTM)	$-96M	$-28M
EPS (TTM)	-$1.02	-$2.96
ROE (TTM)	-8911.0%	-15602.0%
ROA (TTM)	-6247.0%	-12834.0%
ROIC (TTM)	-8911.0%	-15602.0%
Financial Health
Cash	$26M	$22M
Debt	$0	$0
Net Cash/Debt	$26M	$22M
Current Ratio (TTM)	6.49x	8.57x
Quick Ratio (TTM)	6.36x	8.36x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	-0.69
52W Performance	-82.8%	-63.8%
YTD Performance	-71.1%	-58.7%
% from 52W High	-87.0%	-67.8%
% from 52W Low	4.0%	51.2%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.07x
FCF Yield (TTM)	-210.7%	-64.2%
Earnings Yield (TTM)	-226.5%	-69.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	-8,540.5
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View CRVO research

Valuation

P/S Ratio

CRBU

4.55x

CRVO

131.50x

EV/FCF

CRVO

-0.75x

CRBU

-0.20x

Growth & revenue

Revenue Growth TTM

CRBU

10.0%

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

CRBU

15.8%

Profitability & performance

Gross Margin

CRBU

0.0%

CRVO

0.0%

ROE

CRBU

-8911.0%

CRVO

-15602.0%

FCF Yield %

CRVO

-64.2%

CRBU

-210.7%

52-Week Performance

CRVO

-63.8%

CRBU

-82.8%

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

CRVO

CervoMed Inc

Market Cap

CRBU$46M

CRVO$44M

Enterprise Value

CRBU$19M

CRVO$21M

Price

CRBU$0.46

CRVO$3.22

P/E Ratio

CRBUN/A

CRVON/A

P/S Ratio

CRBU4.55x

CRVO131.50x

EV/Sales

CRBU1.94x

CRVO63.70x

EV/EBITDA

CRBU0.00x

CRVO0.00x

P/B Ratio

CRBU1.33x

CRVO1.99x

P/FCF Ratio

CRBUN/A

CRVON/A

EV/FCF

CRBU-0.20x

CRVO-0.75x

PEG Ratio

CRBUN/A

CRVON/A

Forward P/E (NTM)

CRBUN/A

CRVON/A

Forward P/S (NTM)

CRBUN/A

CRVON/A

Revenue (TTM)

CRBU$10M

CRVO$331K

Revenue Growth (YoY)

CRBU10.0%

CRVO-95.7%

Forward Rev Growth

CRBU15.8%

CRVO2153.6%

Gross Margin (TTM)

CRBU0.0%

CRVO0.0%

Operating Margin (TTM)

CRBU0.0%

CRVO0.0%

EBITDA Margin (TTM)

CRBU-1065.1%

CRVO-9406.8%

Net Margin (TTM)

CRBU-1030.4%

CRVO-9160.8%

FCF Margin (TTM)

CRBU-958.5%

CRVO-8444.8%

Net Income (TTM)

CRBU$-103M

CRVO$-30M

FCF (TTM)

CRBU$-96M

CRVO$-28M

EPS (TTM)

CRBU-$1.02

CRVO-$2.96

ROE (TTM)

CRBU-8911.0%

CRVO-15602.0%

ROA (TTM)

CRBU-6247.0%

CRVO-12834.0%

ROIC (TTM)

CRBU-8911.0%

CRVO-15602.0%

Cash

CRBU$26M

CRVO$22M

Debt

CRBU$0

CRVO$0

Net Cash/Debt

CRBU$26M

CRVO$22M

Current Ratio (TTM)

CRBU6.49x

CRVO8.57x

Quick Ratio (TTM)

CRBU6.36x

CRVO8.36x

Debt/Equity (TTM)

CRBU0.00x

CRVO0.00x

Debt/Assets (TTM)

CRBU0.0%

CRVO0.0%

Interest Coverage (TTM)

CRBUN/A

CRVON/A

Net Debt/EBITDA (TTM)

CRBU0.00x

CRVO0.00x

Beta

CRBU2.46

CRVO-0.69

52W Performance

CRBU-82.8%

CRVO-63.8%

YTD Performance

CRBU-71.1%

CRVO-58.7%

% from 52W High

CRBU-87.0%

CRVO-67.8%

% from 52W Low

CRBU4.0%

CRVO51.2%

Asset Turnover (TTM)

CRBU0.06x

CRVO0.07x

FCF Yield (TTM)

CRBU-210.7%

CRVO-64.2%

Earnings Yield (TTM)

CRBU-226.5%

CRVO-69.7%

Dividend Yield (TTM)

CRBUN/A

CRVON/A

Rule of 40

CRBU-948.5

CRVO-8,540.5

EV/GP/RG

CRBUN/A

CRVON/A

Ticker research

View CRBU research View CRVO research

Metric	CRBU Caribou Biosciences Inc	CRVO CervoMed Inc
Market & Valuation
Market Cap	$46M	$44M
Enterprise Value	$19M	$21M
Price	$0.46	$3.22
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	131.50x
EV/Sales	1.94x	63.70x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	1.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$331K
Revenue Growth (YoY)	10.0%	-95.7%
Forward Rev Growth	15.8%	2153.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1065.1%	-9406.8%
Net Margin (TTM)	-1030.4%	-9160.8%
FCF Margin (TTM)	-958.5%	-8444.8%
Net Income (TTM)	$-103M	$-30M
FCF (TTM)	$-96M	$-28M
EPS (TTM)	-$1.02	-$2.96
ROE (TTM)	-8911.0%	-15602.0%
ROA (TTM)	-6247.0%	-12834.0%
ROIC (TTM)	-8911.0%	-15602.0%
Financial Health
Cash	$26M	$22M
Debt	$0	$0
Net Cash/Debt	$26M	$22M
Current Ratio (TTM)	6.49x	8.57x
Quick Ratio (TTM)	6.36x	8.36x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	-0.69
52W Performance	-82.8%	-63.8%
YTD Performance	-71.1%	-58.7%
% from 52W High	-87.0%	-67.8%
% from 52W Low	4.0%	51.2%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.07x
FCF Yield (TTM)	-210.7%	-64.2%
Earnings Yield (TTM)	-226.5%	-69.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	-8,540.5
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View CRVO research